Keith W. Leung

Keith W. Leung

Oncology | Hematology
Valley Professional Center North 3915 Talbot Rd S
Ste 300
Renton, WA 98055

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

ALKBH1 Drives Tumorigenesis and Drug Resistance via tRNA-decoding Reprogramming and Codon-biased Translation.

ALKBH1 Drives Tumorigenesis and Drug Resistance via tRNA-decoding Reprogramming and Codon-biased Translation.

Journal: Cancer discovery
Published: July 19, 2024

CRISPR screening reveals ZNF217 as a vulnerability in high-risk B-cell acute lymphoblastic leukemia.

CRISPR screening reveals ZNF217 as a vulnerability in high-risk B-cell acute lymphoblastic leukemia.

Journal: Theranostics
Published: June 29, 2024

YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies.

YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies.

Journal: Cell
Published: November 18, 2023

Metformin synergizes with gilteritinib in treating FLT3-mutated leukemia via targeting PLK1 signaling.

Metformin synergizes with gilteritinib in treating FLT3-mutated leukemia via targeting PLK1 signaling.

Journal: Cell reports. Medicine
Published: October 31, 2023

METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation.

METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation.

Journal: Journal of hematology & oncology
Published: April 19, 2023

Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemia.

Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemia.

Journal: Science translational medicine
Published: March 29, 2023

RNA m6A reader YTHDF2 facilitates precursor miR-126 maturation to promote acute myeloid leukemia progression.

RNA m6A reader YTHDF2 facilitates precursor miR-126 maturation to promote acute myeloid leukemia progression.

Journal: Genes & diseases
Published: November 27, 2022

TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewal.

TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewal.

Journal: Cell stem cell
Published: July 22, 2022

RNA N6 -methyladenosine reader YTHDC1 is essential for TGF-beta-mediated metastasis of triple negative breast cancer.

RNA N6 -methyladenosine reader YTHDC1 is essential for TGF-beta-mediated metastasis of triple negative breast cancer.

Journal: Theranostics
Published: February 09, 2022

QKI shuttles internal m7G-modified transcripts into stress granules and modulates mRNA metabolism.

QKI shuttles internal m7G-modified transcripts into stress granules and modulates mRNA metabolism.

Journal: Cell
Published: January 26, 2022

METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism.

METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism.

Journal: Cell stem cell
Published: January 11, 2022

Incremental Elevations in TNFα and IL6 in the Human Colon and Procancerous Changes in the Mucosal Transcriptome Accompany Adiposity.

Incremental Elevations in TNFα and IL6 in the Human Colon and Procancerous Changes in the Mucosal Transcriptome Accompany Adiposity.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: January 24, 2018
Showing 1-12 of 14

Last Updated: 09/26/2026